These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1083406)

  • 1. Physician-controlled source selection--a suggested approach to substitution.
    Chadwick BM
    J Leg Med (N Y); 1976 Mar; 4(3):27-32. PubMed ID: 1083406
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of bioavailability to the pharmacist.
    Canada AT
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):346-8. PubMed ID: 1158541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug substitution--boon to consumers versus legal trap for the professional.
    Brennan BJ
    J Leg Med (N Y); 1976 Mar; 4(3):20-5. PubMed ID: 1083405
    [No Abstract]   [Full Text] [Related]  

  • 4. Generic prescribing.
    Pediatrics; 1976 Feb; 57(2):275-7. PubMed ID: 1250664
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Antisubstitution vs. cooperative substitution.
    Jones ME; Helling DK; Widmer RB
    Am Fam Physician; 1976 Jul; 14(1):27. PubMed ID: 937160
    [No Abstract]   [Full Text] [Related]  

  • 6. Generic substitution laws--physicians' liability.
    Trout ME
    J Leg Med (N Y); 1977 Jul; 5(7):14-6. PubMed ID: 301915
    [No Abstract]   [Full Text] [Related]  

  • 7. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation.
    Segal R; Grines LL; Pathak DS
    Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic issues in the antisubstitution controversy.
    Sharpe TR
    Am J Pharm Sci Support Public Health; 1977; 149(2):53-9. PubMed ID: 910879
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of bioavailability data by practitioners. Part 2: Preliminary report of evaluation skills of pharmacists and physicians.
    Vinson BE; Schumacher GE
    Am J Hosp Pharm; 1976 Nov; 33(11):1164-6. PubMed ID: 998634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Legal implications of generic drug substitution.
    Chewning JB
    Ohio State Med J; 1975 May; 71(5):323-6. PubMed ID: 1128867
    [No Abstract]   [Full Text] [Related]  

  • 11. Guidelines for pharmacists performing product selection.
    Am Pharm; 1990 Jul; NS30(7):40-1. PubMed ID: 2363394
    [No Abstract]   [Full Text] [Related]  

  • 12. Physicians' attitudes toward generic drug substitution by pharmacists.
    Brust M; Hawkins CF; Grayson D
    Tex Med; 1990 Mar; 86(3):45-9. PubMed ID: 2333636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescriptions enter the political arena.
    Regier H
    J Leg Med (N Y); 1974; 2(2):24-30. PubMed ID: 4545342
    [No Abstract]   [Full Text] [Related]  

  • 14. Generic vs. brand name drugs--patients, pharmacists, physicians: caught in the middle.
    Felch WC
    Internist; 1979 May; 20(4):3-5. PubMed ID: 10242131
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacists' and physicians' responses to the South Carolina Product Selection Act of 1978.
    Sumner ED; Karig AW; Hunt HH
    Contemp Pharm Pract; 1982; 5(2):124-9. PubMed ID: 10256911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTC: our model product selection law relies on the pharmacist's expertise.
    Holmes PD
    Pharm Times; 1979 Feb; 45(2):36-9. PubMed ID: 10240271
    [No Abstract]   [Full Text] [Related]  

  • 17. Attitudes of pharmacists and physicians toward Florida's drug product selection law.
    Vuturo GJ; McCormick WC; Krischer JP
    Contemp Pharm Pract; 1980; 3(3):156-62. PubMed ID: 10247871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In defense of the Drug Research Board.
    Azarnoff DL
    JAMA; 1975 Aug; 233(5):425-6. PubMed ID: 1173852
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic substitution practices in short-term hospitals.
    Doering PL; Klapp DL; McCormick WC; Russell WL
    Am J Hosp Pharm; 1982 Jun; 39(6):1028-32. PubMed ID: 7102686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug product selection and the law.
    Fink JL
    Contemp Pharm Pract; 1979; 2(3):128-31. PubMed ID: 10242846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.